Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
33323461
PubMed Central
PMC7792657
DOI
10.2215/cjn.09070620
PII: 01277230-202101000-00012
Knihovny.cz E-zdroje
- Klíčová slova
- capacity, conservative kidney management, global health, kidney failure, survey,
- MeSH
- chronické selhání ledvin terapie MeSH
- dostupnost zdravotnických služeb statistika a číselné údaje MeSH
- internacionalita MeSH
- konzervativní terapie * normy MeSH
- kvalita zdravotní péče * MeSH
- lidé MeSH
- náboženství MeSH
- průzkumy a dotazníky MeSH
- rozvojové země statistika a číselné údaje MeSH
- sdílené rozhodování MeSH
- sociální opora MeSH
- týmová péče o pacienty statistika a číselné údaje MeSH
- vyspělé země statistika a číselné údaje MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND AND OBJECTIVES: People with kidney failure typically receive KRT in the form of dialysis or transplantation. However, studies have suggested that not all patients with kidney failure are best suited for KRT. Additionally, KRT is costly and not always accessible in resource-restricted settings. Conservative kidney management is an alternate kidney failure therapy that focuses on symptom management, psychologic health, spiritual care, and family and social support. Despite the importance of conservative kidney management in kidney failure care, several barriers exist that affect its uptake and quality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The Global Kidney Health Atlas is an ongoing initiative of the International Society of Nephrology that aims to monitor and evaluate the status of global kidney care worldwide. This study reports on findings from the 2018 Global Kidney Health Atlas survey, specifically addressing the availability, accessibility, and quality of conservative kidney management. RESULTS: Respondents from 160 countries completed the survey, and 154 answered questions pertaining to conservative kidney management. Of these, 124 (81%) stated that conservative kidney management was available. Accessibility was low worldwide, particularly in low-income countries. Less than half of countries utilized multidisciplinary teams (46%); utilized shared decision making (32%); or provided psychologic, cultural, or spiritual support (36%). One-quarter provided relevant health care providers with training on conservative kidney management delivery. CONCLUSIONS: Overall, conservative kidney management is available in most countries; however, it is not optimally accessible or of the highest quality.
Australasian Kidney Trials Network University of Queensland Brisbane Queensland Australia
Department of Community Health Sciences University of Calgary Calgary Alberta Canada
Department of Family Medicine University of Ottawa Ottawa Ontario Canada
Department of Medicine University of Calgary Calgary Alberta Canada
Department of Nephrology General University Hospital Charles University Prague Czech Republic
Department of Renal Medicine Singapore General Hospital Singapore
Division of Nephology and Hypertension Saint Louis University St Louis Missouri
Division of Nephrology and Hypertension University of Cape Town Cape Town South Africa
Division of Nephrology Bezmialem Vakif University Istanbul Turkey
George Institute for Global Health University of New South Wales New Delhi India
Imperial College Renal and Transplant Centre Hammersmith Hospital London England
Key Lab of Renal Disease Ministry of Health of China Beijing China
Kidney and Hypertension Research Unit University of Cape Town Cape Town South Africa
Kidney Research Center Department of Nephrology Chang Gung Memorial Hospital Linkou Taiwan
Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia
Nephrology Division Department of Internal Medicine The Specialty Hospital Amman Jordan
Peking Tsinghua Center for Life Sciences Beijing China
Prasanna School of Public Health Manipal Academy of Higher Education Manipal Karnataka India
Renal Division Department of Medicine Peking University 1st Hospital Beijing China
Translational Research Institute Brisbane Queensland Australia
Zobrazit více v PubMed
Anand S, Kurella Tamura M, Chertow GM: The elderly patients on hemodialysis. Minerva Urol Nefrol 62: 87–101, 2010 PubMed PMC
Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O’Donoghue DJ, Morton RL, Obrador GT; Kidney Disease Improving Global Outcomes : Executive summary of the Kidney Disease Improving Global Outcomes controversies conference on supportive care in chronic kidney disease: Developing a roadmap to improving quality care. Available at: https://kdigo.org/. Kidney Int 88: 447–459, 2015. PubMed
Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, Josland E, Brennan F, Stallworthy EJ, Siva B, Miller C, Urban AK, Sajiv C, Glavish RN, May S, Langham R, Walker R, Fassett RG, Morton RL, Stewart C, Phipps L, Healy H, Berquier I: ANZSN renal supportive care 2013: Opinion pieces [corrected] [published correction appears in Nephrology (Carlton) 19: 175, 2014]. Nephrology (Carlton) 18: 401–454, 2013 PubMed
Davison SN, Tupala B, Wasylynuk BA, Siu V, Sinnarajah A, Triscott J: Recommendations for the care of patients receiving conservative kidney management: Focus on management of CKD and symptoms. Clin J Am Soc Nephrol 14: 626–634, 2019 PubMed PMC
Ladin K, Pandya R, Kannam A, Loke R, Oskoui T, Perrone RD, Meyer KB, Weiner DE, Wong JB: Discussing conservative management with older patients with CKD: An interview study of nephrologists. Am J Kidney Dis 71: 627–635, 2018 PubMed PMC
Grubbs V, Tuot DS, Powe NR, O’Donoghue D, Chesla CA: System-level barriers and facilitators for foregoing or withdrawing dialysis: A qualitative study of nephrologists in the United States and England. Am J Kidney Dis 70: 602–610, 2017 PubMed PMC
Bello AK, Levin A, Lunney M, Osman MA, Ye F, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Davison SN, Ghnaimat M, Harden P, Htay H, Jha V, Kalantar-Zadeh K, Kerr PG, Klarenbach S, Kovesdy CP, Luyckx VA, Neuen BL, O’Donoghue D, Ossareh S, Perl J, Rashid HU, Rondeau E, See E, Saad S, Sola L, Tchokhonelidze I, Tesar V, Tungsanga K, Turan Kazancioglu R, Wang AY, Wiebe N, Yang CW, Zemchenkov A, Zhao MH, Jager KJ, Caskey F, Perkovic V, Jindal KK, Okpechi IG, Tonelli M, Feehally J, Harris DC, Johnson DW: Status of care for end stage kidney disease in countries and regions worldwide: International cross sectional survey. BMJ 367: l5873, 2019 PubMed
Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, Okpechi IG, Salako BL, Wiebe N, Ye F, Tonelli M, Levin A: Global Kidney Health Atlas (GKHA): Design and methods. Kidney Int Suppl (2011) 7: 145–153, 2017 PubMed PMC
Bello AK, Levin A, Tonelli M, Okpechi IG, Feehally J, Harris D, Jindal K, Salako BL, Rateb A, Osman MA, Qarni B, Saad S, Lunney M, Wiebe N, Ye F, Johnson DW: Assessment of global kidney health care status. JAMA 317: 1864–1881, 2017 PubMed PMC
International Society of Nephrology : Global Kidney Health Atlas. Available at: https://www.theisn.org/in-action/research/global-kidney-health-atlas/. Accessed August 26, 2019
International Society of Nephrology : Regional Boards. Available at: https://www.theisn.org/about-isn/governance/regional-boards/. Accessed February 14, 2020
Murtagh FE, Burns A, Moranne O, Morton RL, Naicker S: Supportive care: Comprehensive conservative care in end-stage kidney disease. Clin J Am Soc Nephrol 11: 1909–1914, 2016 PubMed PMC
National Institute for Health and Care Excellence: Renal replacement therapy and conservative management. NICE guideline [NG107], 2018. Available at: https://www.nice.org.uk/guidance/ng107. Accessed September 17, 2019 PubMed
Harrison TG, Tam-Tham H, Hemmelgarn BR, James MT, Sinnarajah A, Thomas CM: Identification and prioritization of quality indicators for conservative kidney management. Am J Kidney Dis 73: 174–183, 2019 PubMed
University of Bristol: Prepare for kidney care trial. Available at: http://www.bristol.ac.uk/population-health-sciences/projects/prepare-kc-trial/. Accessed September 17, 2019
Alberta Health Services : Conservative Kidney Management (CKM), 2016. Available at: https://www.ckmcare.com. Accessed September 17, 2019
Fortnum D, Smolonogov T, Walker R, Kairaitis L, Pugh D: ‘My kidneys, my choice, decision aid’: Supporting shared decision making. J Ren Care 41: 81–87, 2015 PubMed
Davis JL, Davison SN: Hard choices, better outcomes: A review of shared decision-making and patient decision aids around dialysis initiation and conservative kidney management. Curr Opin Nephrol Hypertens 26: 205–213, 2017 PubMed
St. George and Sutherland Hospitals, Renal Department: Information for patients about advanced kidney disease: Dialysis and non-dialysis treatments, 2017. Available at: https://stgrenal.org.au/sites/default/files/upload/Predialysis/Patient information about dialysis 2018_V2.pdf. Accessed February 15, 2020
Harris DCH, Davies SJ, Finkelstein FO, Jha V, Donner JA, Abraham G, Bello AK, Caskey FJ, Garcia GG, Harden P, Hemmelgarn B, Johnson DW, Levin NW, Luyckx VA, Martin DE, McCulloch MI, Moosa MR, O’Connell PJ, Okpechi IG, Pecoits Filho R, Shah KD, Sola L, Swanepoel C, Tonelli M, Twahir A, van Biesen W, Varghese C, Yang CW, Zuniga C; Working Groups of the International Society of Nephrology’s 2nd Global Kidney Health Summit: Increasing access to integrated ESKD care as part of universal health coverage. Kidney Int 95: S1–S33, 2019 PubMed
Hole B, Hemmelgarn B, Brown E, Brown M, McCulloch MI, Zuniga C, Andreoli SP, Blake PG, Couchoud C, Cueto-Manzano AM, Dreyer G, Garcia G, Jager KJ, McKnight M, Morton RL, Murtagh FEM, Naicker S, Obrador GT, Perl J, Rahman M, Shah KD, Van Biesen W, Walker RC, Yeates K, Zemchenkov A, Zhao MH, Davies SJ, Caskey FJ: Supportive care for end-stage kidney disease: An integral part of kidney services across a range of income settings around the world. Kidney Int Suppl (2011) 10: e86–e94, 2020 PubMed PMC
Inequities in kidney health and kidney care